1. Comparative study of programmed cell death ligand-1 immunohistochemistry assays using 22C3 and 28-8 antibodies for non-small cell lung cancer: Analysis of 420 surgical specimens from Japanese patients. (November 2018) Authors: Saito, Tomohito; Tsuta, Koji; Ishida, Mitsuaki; Ryota, Hironori; Takeyasu, Yuki; Fukumoto, Kento J.; Matsui, Hiroshi; Taniguchi, Yohei; Yanagimoto, Hiroaki; Kurata, Takayasu; Murakawa, Tomohiro Journal: Lung cancer Issue: Volume 125(2018) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (8th June 2021) Authors: Takeyasu, Yuki; Yoshida, Tatsuya; Motoi, Noriko; Teishikata, Takashi; Tanaka, Midori; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Kakishima, Hiroki; Tsuchida, Takaaki; Yamamoto, Noboru; Ohe, Yuichiro; Yatabe, Yasushi Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 7(2021) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. End‐of‐life impact of concurrent diabetes mellitus and adrenal insufficiency as immune‐related adverse events in an advanced non‐small cell lung cancer patient. Issue 21 (4th October 2022) Authors: Nakamura, Tomoaki; Takeyasu, Yuki; Yoshida, Tatsuya; Ohashi, Ken; Ohe, Yuichiro Journal: Thoracic cancer Issue: Volume 13:Issue 21(2022) Page Start: 3073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (21st April 2021) Authors: Takeyasu, Yuki; Yoshida, Tatsuya; Motoi, Noriko; Teishikata, Takashi; Tanaka, Midori; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Kakishima, Hiroki; Tsuchida, Takaaki; Yamamoto, Noboru; Ohe, Yuichiro; Yatabe, Yasushi Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 7(2021) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors. (2021) Authors: Takeyasu, Yuki; Okuma, Hitomi S.; Kojima, Yuki; Nishikawa, Tadaaki; Tanioka, Maki; Sudo, Kazuki; Shimoi, Tatsunori; Noguchi, Emi; Arakawa, Ayumu; Mori, Taisuke; Sunami, Kuniko; Kubo, Takashi; Kohno, Takashi; Akihiko, Yoshida; Yamamoto, Noboru; Yonemori, Kan Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer. (April 2023) Authors: Akagi, Kazumasa; Yagishita, Shigehiro; Ohuchi, Mayu; Hayashi, Yoshiharu; Takeyasu, Yuki; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Mukae, Hiroshi; Ohe, Yuichiro; Hamada, Akinobu Journal: Lung cancer Issue: Volume 178(2023) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report. Issue 12 (2nd November 2017) Authors: Takeyasu, Yuki; Satake, Atsushi; Azuma, Yoshiko; Tsubokura, Yukie; Yoshimura, Hideaki; Hotta, Masaaki; Nakanishi, Takahisa; Fujita, Shinya; Nakaya, Aya; Ito, Tomoki; Nomura, Shosaku Journal: Clinical case reports Issue: Volume 5:Issue 12(2017) Page Start: 2047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗